Johnson & Johnson Vision Care, Inc. recalls ACUVUE¿ OASYS MAX 1-Day MULTIFOCAL
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Due to defects (bubbles/voids) identified during standard finished goods testing
- Products
-
- ACUVUE¿ OASYS MAX 1-Day MULTIFOCAL
- Company
- Johnson & Johnson Vision Care, Inc.
- Where it was sold
-
Worldwide - U.S. Nationwide distribution including in the states of AL, AZ, CA, CO, DE, FL, GA, HI, IA, IL, IN, KN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NV, NY, OH, PA, SC TN, TX, UT, VA, WA, WI, and WY. The countries of Belgium, Bermuda, Canada, Switzerland, Denmark, Germany, Spain, France, United Kingdom, Italy, Netherlands, Poland, Sweden, Singapore, and South Korea.
Nationwide
- Units affected
- 114,165 lenses
- About this recall
- ACUVUE¿ OASYS MAX 1-Day MULTIFOCAL